Back to Research Hub
Bioventus Inc.
BVS
$14.04+0.02 (+0.14%)
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products,…
StreetsValue research for Bioventus Inc. (BVS)
Members get the full report for Bioventus Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.